0000000000266554

AUTHOR

Boris R. Haxel

showing 15 related works from this author

Olfactory training is helpful in postinfectious olfactory loss: A randomized, controlled, multicenter study

2013

Objectives/Hypothesis: The aim of this study was to evaluate the effects of olfactory training (OT) on olfactory function in patients with persistent postinfectious olfactory dysfunction (PIOD). Study Design: Randomized, single-blind, controlled, multicenter crossover study. Methods: Twelve tertiary university medical centers participated. Investigations were performed at three visits (base- line, after 18 weeks, and after 36 weeks), including only subjects with PIOD of <24-months duration. At each visit, partici- pants received detailed assessment of olfactory function. Seventy subjects trained with high concentrations of four odors for 18 weeks; the other half (n 5 74) trained with low co…

Olfactory systemmedicine.medical_specialtybusiness.industryAnosmiaOlfactionCrossover studySurgeryRegimenOtorhinolaryngologyMulticenter studyHyposmiaInternal medicinemedicineIn patientmedicine.symptombusinessThe Laryngoscope
researchProduct

Vascular endothelial growth factor expression in nasal polyps of aspirin-intolerant patients.

2012

Objective To study differences between aspirin-tolerant patients and aspirin-intolerant patients concerning vascular endothelial growth factor (VEGF) expression. Recent publications strongly suggest the involvement of VEGF and its receptors in the pathophysiologic process of nasal polyps. Design We subjected 43 polyp specimens to semiquantitative immunohistochemical analysis. We quantified VEGF and its receptors (Flk, Flt, and neuropilin) in all samples. To gain insight into potential VEGF-mediated cellular responses, we determined proliferative (Ki67) and apoptotic (caspase 3) indices. Patients Polyp samples were obtained from 22 aspirin-intolerant patients and from 21 aspirin-tolerant pat…

AdultMaleVascular Endothelial Growth Factor APathologymedicine.medical_specialtyAdolescentApoptosisStatistics Nonparametricchemistry.chemical_compoundNasal Polypsotorhinolaryngologic diseasesNeuropilinMedicineHumansNasal polypsReceptorAspirinAspirinbusiness.industryCaspase 3General MedicineMiddle Agedmedicine.diseaseImmunohistochemistryPathophysiologyVascular endothelial growth factorVascular endothelial growth factor AKi-67 AntigenReceptors Vascular Endothelial Growth FactorOtorhinolaryngologychemistryImmunohistochemistrySurgeryFemalebusinessmedicine.drugArchives of otolaryngology--headneck surgery
researchProduct

Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and…

2019

Abstract Background The combination of cisplatin, 5-fluorouracil (5-FU) and cetuximab (PFC) is the reference first-line treatment for recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN). We analysed whether treatment intensification by the addition of docetaxel to PFC improved efficacy in R/M SCCHN. Methods A total of 180 patients with R/M SCCHN (1:1) were assigned to receive either cisplatin (40 mg/m2), docetaxel (40 mg/m2) and 5-FU (2000 mg/m2) at days 1 and 8 and cetuximab (400/250 mg/m2) at days 1, 8 and 15 (DPFC) or standard cisplatin (100 mg/m2) at day 1, 5-FU (1000 mg/m2) at days 1–4 and cetuximab (400/250 mg/m2) at days 1, 8 and 15 (PFC). Chemotherapy was…

0301 basic medicineOncologyAdultMaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmentMedizinCetuximabDocetaxelDisease-Free SurvivalDrug Administration Schedule03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesAgedCisplatinChemotherapyCetuximabbusiness.industrySquamous Cell Carcinoma of Head and NeckHead and neck cancerHazard ratioMiddle AgedInterim analysismedicine.disease030104 developmental biologyOncologyDocetaxelFluorouracil030220 oncology & carcinogenesisFemaleFluorouracilCisplatinbusinessmedicine.drug
researchProduct

Comparison of subjective olfaction ratings in patients with and without olfactory disorders

2012

AbstractObjective:Olfactory dysfunction is common. The reliability of self-assessment tools for smell testing is still controversial. This study aimed to provide new data about the accuracy of olfactory self-assessment compared with a standardised smell test.Design:Prospective, controlled, cohort study of patients with olfactory disorders and healthy controls.Subjects:Ninety-six patients with a smell deficit and 71 controls were asked to rate their sense of smell on a visual analogue scale. Their olfactory abilities were also evaluated with the Sniffin' Sticks tests.Results:The whole cohort showed a significant correlation between visual analogue scale smell scores and Sniffin' Sticks total…

AdultMalemedicine.medical_specialtyAdolescentVisual analogue scaleOlfactionAudiologySeverity of Illness IndexDiagnostic Self EvaluationOlfaction DisordersYoung AdultPredictive Value of TestsSeverity of illnessHumansMedicineProspective StudiesYoung adultChildProspective cohort studyAgedAged 80 and overbusiness.industryReproducibility of ResultsGeneral MedicineMiddle AgedSmellOtorhinolaryngologySensory ThresholdsPredictive value of testsOdorantsCohortFemalebusinessCohort studyThe Journal of Laryngology &amp; Otology
researchProduct

Olfactory Dysfunction After Head Injury

2008

Objective: To determine the incidence of olfactory dysfunction after head trauma using clinical and radiologic findings, quantitative assessment, and electro-physiologic methods. Participants: A total of 190 patients with head trauma of different severity (n = 32 with mild traumatic brain injury (TBI), n = 94 with signs of moderate TBI, and n = 64 with severe TBI) 6 to 32 months prior to the study. Design: Patients were selected retrospectively, surveyed by telephone (n = 190), and screened for olfactory function with Brief Smell Identification Test (n = 82). Those with olfactory dysfunction were assessed as outpatients using the Sniffin' Sticks (n = 19) and olfactory-evoked potential recor…

AdultMaleRiskOlfactory systemmedicine.medical_specialtyTraumatic brain injuryAnosmiaPhysical Therapy Sports Therapy and RehabilitationOlfactionHead traumaCohort StudiesOlfaction DisordersYoung AdultHematomamedicineHumansEvoked PotentialsAgedRetrospective Studiesbusiness.industryIncidence (epidemiology)RehabilitationHead injuryMiddle AgedOlfactory Perceptionmedicine.diseaseIntracranial Hemorrhage TraumaticSurgeryBrain InjuriesSensory ThresholdsAnesthesiaFemaleNeurology (clinical)medicine.symptombusinessJournal of Head Trauma Rehabilitation
researchProduct

Olfaction in chemotherapy for head and neck malignancies

2015

Abstract Objective Systemic chemotherapy for different malignancies occurs alongside various side effects, including reduced sensory function. To date, little is known about the effect of chemotherapeutic agents on olfaction. The aim of this study was to provide new data about changes in sense of smell during chemotherapy among patients with advanced squamous cell carcinomas of the head and neck region. Methods In a prospective, controlled cohort study of patients undergoing up to three courses of chemotherapy (cis- or carboplatin, 5-fluorouracil and docetaxel), olfaction was evaluated prior to and directly following completing a cycle, as well as 3 weeks later with the beginning of the nex…

MaleOncologymedicine.medical_treatmentDocetaxelSystemic therapyCarboplatinCohort StudiesOlfaction Disorderschemistry.chemical_compound0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsProspective Studies030212 general & internal medicineAged 80 and overSmokingAge FactorsGeneral MedicineMiddle AgedDocetaxelHead and Neck NeoplasmsSensory Thresholds030220 oncology & carcinogenesisCarcinoma Squamous CellFemaleTaxoidsFluorouracilmedicine.drugCohort studyAdultmedicine.medical_specialtyDifferential ThresholdOlfaction03 medical and health sciencesInternal medicinemedicineHumansLaryngeal NeoplasmsAgedCisplatinChemotherapySquamous Cell Carcinoma of Head and Neckbusiness.industryCancerPharyngeal Neoplasmsmedicine.diseaseCarboplatinSurgeryOtorhinolaryngologychemistryControlled Before-After StudiesSurgeryCisplatinbusinessAuris Nasus Larynx
researchProduct

Correlation of Skin Test Results and Specific Immunoglobulin E Blood Levels with Nasal Provocation Testing for House-Dust Mite Allergies

2016

Background Allergen-specific immunotherapy for house-dust mite (HDM) allergies is associated with lower success rates when compared with similar treatments for other inhalant allergens, such as grass or birch. One reason might be the greater difficulty in diagnosing patients with assumed HDM allergies because symptoms occur perennially and may differ from those of a conventional allergic rhinitis. Objective The aim of the study was to compare the different methods of diagnosis in patients with assumed HDM allergy. Methods We performed a retrospective analysis of nasal provocation tests (NPT) from patients (n = 161) evaluated for Dermatophagoides pteronyssinus (n = 127) and Dermatophagoides …

AdultMaleAllergyDermatophagoides pteronyssinusmedicine.medical_treatmentProvocation testNasal provocation testYoung Adult03 medical and health sciences0302 clinical medicinePredictive Value of TestsHypersensitivitymedicineMiteAnimalsHumansImmunology and AllergyAntigens Dermatophagoides030223 otorhinolaryngologySensitizationRetrospective StudiesSkin TestsDesensitization (medicine)House dust miteDermatophagoides farinaebiologybusiness.industryGeneral MedicineImmunoglobulin EMiddle Agedmedicine.diseasebiology.organism_classificationmedicine.anatomical_structure030228 respiratory systemOtorhinolaryngologyDesensitization ImmunologicPredictive value of testsImmunologyFemaleImmunizationbusinessAmerican Journal of Rhinology &amp; Allergy
researchProduct

Controlled trial for long-term low-dose erythromycin after sinus surgery for chronic rhinosinusitis

2014

Objectives/Hypothesis The efficacy of macrolides in chronic rhinosinusitis (CRS) is still under controversy. To date, only two double-blind, placebo-controlled studies have been published with differing results. None of these studies investigated the possible benefit of macrolides in the postoperative period. We conducted an investigator-initiated clinical trial using 250-mg erythromycin once a day over a period of 3 months, beginning the administration of either erythromycin or placebo 2 weeks after a surgical intervention for CRS. Study Design Randomized double-blind, placebo-controlled trial. Methods The concentrations of eosinophilic cationic protein (ECP) and myeloperoxidase in nasal s…

Eosinophil cationic proteinmedicine.medical_specialtybusiness.industryVisual analogue scaleErythromycinPlacebomedicine.diseaselaw.inventionClinical trialOtorhinolaryngologyRandomized controlled triallawAnesthesiaInternal medicineotorhinolaryngologic diseasesmedicineSecondary Outcome MeasureNasal polypsbusinessmedicine.drugThe Laryngoscope
researchProduct

Evaluation of the efficacy of the ‘nasal airflow-inducing manoeuvre’ for smell rehabilitation in laryngectomees by means of the Sniffin′ Sticks test

2011

Clin. Otolaryngol. 2011, 36, 17–23 Objective:  To determine the efficacy of the nasal airflow-inducing manoeuvre (NAIM) as a method for olfactory rehabilitation in laryngectomees by the means of the Sniffin′ Sticks test. Study design:  Prospective open interventional trial. Setting:  Tertiary academic hospital. Participants:  Thirty-seven patients after laryngectomy have been screened and 25 patients have been included into the study. The participant’s sense of smell was tested with the Sniffin′ Sticks test before and after learning the nasal airflow inducing manoeuvre. The individual level of threshold, discrimination and identification (TDI) was determined and the individual threshold, di…

medicine.medical_specialtyRehabilitationbusiness.industrymedicine.medical_treatmentrespiratory systemAudiologyTest (assessment)Surgerylaw.inventionLaryngectomyOtorhinolaryngologyRandomized controlled triallawSensory thresholdotorhinolaryngologic diseasesmedicineClinical endpointNasal airflowbusinessProspective cohort studyClinical Otolaryngology
researchProduct

Dysregulated Survivin Expression in Nasal Polyps of Individuals with Aspirin Exacerbated Respiratory Disease

2012

Background A derailed balance of cell proliferation and apoptosis is presumed to result in cell hyperplasia as a typical feature of nasal polyps. Survivin, a protein of the inhibitors of the apoptosis family is proposed to promote polyp formation. However, studies concerning survivin expression in chronic rhinosinusitis (CRS) with nasal polyps are rare and the specificity of the survivin expression in nasal polyps from individuals with aspirin-exacerbated respiratory disease (AERD) has not been investigated. Methods Immunohistochemical survivin expression analysis was performed. Samples were taken from the ethmoid sinus of individuals with CRS with nasal polyps with and without AERD during …

AdultMaleVascular Endothelial Growth Factor APathologymedicine.medical_specialtySurvivinApoptosisInhibitor of Apoptosis ProteinsDrug HypersensitivityYoung AdultNasal PolypsEthmoid SinusWestern blotSurvivinotorhinolaryngologic diseasesmedicineHumansImmunology and AllergyNasal polypsSinusitisneoplasmsCells CulturedRhinitisAspirinmedicine.diagnostic_testbusiness.industryRespiratory diseaseGeneral MedicineMiddle AgedHyperplasiamedicine.diseasePathophysiologyOtorhinolaryngologyApoptosisChronic DiseaseDisease ProgressionImmunohistochemistryFemalebusinessAmerican Journal of Rhinology &amp; Allergy
researchProduct

Cetuximab, fluorouracil (5-FU), cisplatin, and docetaxel as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma…

2013

e17021 Background: This study investigates efficacy and toxicity of docetaxel added to cetuximab, cisplatin and 5-FU for patients with R/M SCCHN. We here report a planned second interim analysis to compare response rates between arms in order to decide on continuing to full accrual. Methods: Inclusion criteria were: stage III/IV R/M SCCHN and ECOG 0-1. Patients were randomized to arm A: cetuximab (standard dose) plus a maximum of 6 cycles of docetaxel (40 mg/m², day 1+8), cisplatin (40 mg/m², day 1+8) and 5-FU (2000 mg/m², day 1+8) or to arm B: cetuximab (standard dose), cisplatin (100 mg/m², day 1) and 5-FU (1000 mg/m², day 1-4). Treatment was administered until progression or intolerabil…

CisplatinOncologyCancer Researchmedicine.medical_specialtyCetuximabbusiness.industryInterim analysisClinical trialOncologyDocetaxelFluorouracilInternal medicineInterimToxicitymedicinebusinessmedicine.drugJournal of Clinical Oncology
researchProduct

The Candy Smell Test in Clinical Routine

2011

Background The “Candy Smell Test” (CST) has been introduced as a new testing method for the evaluation of the human sense of smell. In contrast to other established orthonasal smell tests, the CST addresses the retronasal application of odors, typical for food aroma effects during mastication and swallowing. The aim of this study was to evaluate the CST in a clinical setting in patients with olfactory dysfunction and normal controls against the Sniffin’ Sticks test. Furthermore, cutoff points for normal and pathological results in the CST should be determined. Methods The olfactory performance of 96 patients presenting with olfactory disorders and 71 healthy controls was evaluated with the …

AdultMalemedicine.medical_specialtyAdolescentMEDLINEAudiologyCandyOlfaction DisordersReference ValuesParanasal SinusesHumansImmunology and AllergyMedicineChildAgedDiagnostic Tests Routinebusiness.industryDisease progressionDiagnostic testGeneral MedicineMiddle AgedHuman senseClinical routineTest (assessment)SmellOtorhinolaryngologyReference valuesDisease ProgressionFeasibility StudiesFemalebusinessAmerican Journal of Rhinology &amp; Allergy
researchProduct

Recovery of olfaction after sinus surgery for chronic rhinosinusitis: A review

2019

Objective Investigation of the postoperative olfactory function after sinus surgery for chronic rhinosinusitis (CRS) with and without polyps in a review. Data sources PubMed. Review methods A comprehensive literature search was conducted through June 2018 using relevant keywords. The titles/abstracts were reviewed to identify studies evaluating the sense of smell in CRS-patients pre- and postoperatively by either using the whole or parts of the University of Pennsylvania Smell Identification Test or the Sniffin' Sticks test. Study characteristics and outcome data of the included studies were extracted. Results In total, 106 studies were retrieved. Twenty-four studies comprising 1,956 patien…

medicine.medical_specialtyChronic rhinosinusitisAnosmiaOlfaction03 medical and health sciences0302 clinical medicineotorhinolaryngologic diseasesmedicineHumansNasal polypsSinusitis030223 otorhinolaryngologyRhinitisPrior Surgerybusiness.industryRecovery of FunctionSinus surgerymedicine.diseaseSurgeryStudy CharacteristicsSmellOtorhinolaryngology030220 oncology & carcinogenesisChronic Diseasemedicine.symptomOutcome databusinessThe Laryngoscope
researchProduct

Course of olfaction after sinus surgery for chronic rhinosinusitis

2017

Background The influence of surgery on olfaction in patients who suffer from chronic rhinosinusitis (CRS) is still not fully understood. Most particularly, the time course of the recovery is poorly studied. Methods The prospective study describes the results of the Sniffin' Sticks identification test in 41 subjects before (V1), 2 weeks after (V2), and 6 months after (V3) endonasal sinus surgery (ESS). Influencing factors (gender, revision surgery, nasal polyposis, and initial olfactory score) on the changes of the smell testing were evaluated. Results The whole cohort showed a significant improvement in Identification scores, from 8.63 to 10.24 after 2 weeks and to 10.68 after 6 months. Pat…

medicine.medical_specialtybusiness.industryChronic rhinosinusitisGeneral MedicineOlfactionSinus surgerymedicine.diseaseGastroenterologySurgery03 medical and health sciences0302 clinical medicineQuality of life030220 oncology & carcinogenesisInternal medicineCohortmedicineNasal polypsIn patient030223 otorhinolaryngologyProspective cohort studybusinessLaryngoscope Investigative Otolaryngology
researchProduct

Prostaglandin E2 activates the ciliary beat frequency of cultured human nasal mucosa via the second messenger cyclic adenosine monophosphate.

2001

Prostaglandins influence the ciliary beat frequency (CBF) of ciliated nasal epithelial cells and a stimulatory effect has been described for prostaglandin E2 (PGE2). Until now, it is not known whether PGE2 has direct ciliostimulatory properties or acts through a second messenger. In this study we investigated whether cyclic adenosine monophosphate (cAMP) is implicated in the signal transduction pathway of PGE2-induced activation of CBF. Ciliated cells of the nasal mucosa were cultured for up to 5 days whereafter the culture medium was removed and the cells were incubated with different concentrations of test solutions. The ciliated cells were recorded under a phase-contrast microscope and v…

AdultMalemedicine.medical_specialtyStimulationMucous membrane of noseBiologyIn Vitro TechniquesSecond Messenger SystemsDinoprostonechemistry.chemical_compoundInternal medicinemedicineCyclic AMPHumansCyclic adenosine monophosphateCiliaProstaglandin E2Cells CulturedAgedDose-Response Relationship DrugColforsinEpithelial CellsGeneral MedicineMiddle AgedEpitheliumCell biologyNasal Mucosamedicine.anatomical_structureEndocrinologyOtorhinolaryngologychemistryCell cultureSecond messenger systemFemaleSignal transductionmedicine.drugSignal TransductionEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
researchProduct